MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Revenue
$20,874K
Net Income
-$69,160K
Net Profit Margin
-331.32%
EPS
-$0.77
Unit: Thousand (K) dollars
Revenue Breakdown
License And Collaboration Revenu...
Product
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Total revenue
20,874
18,265
17,336
20,750
Cost of product sales
243
262
14*
-
Research and development
61,891
65,263
64,408
67,908
General and administrative
-
-
-
32,839
Selling, general and administrative
31,750
31,555
39,182*
-
Total operating expenses
93,884
97,080
103,604
100,747
Loss from operations
-73,010
-78,815
-86,268
-79,997
Interest and other income, net
5,033
5,826
5,686
6,274
Interest expense
345
336
346
393
Total other income, net
4,688
5,490
5,340
5,881
Loss before income taxes
-68,322
-73,325
-80,928
-74,116
Income tax expense
5
8
71
-
Net loss
-68,327
-73,333
-80,999
-74,116
Unrealized gain on short-term investments
-
-
260
-
Unrealized loss on short-term investments
-833
-1,404
-
-
Comprehensive loss
-69,160
-74,737
-80,739
-
Basic EPS
-0.77
-0.83
-0.917
-0.85
Diluted EPS
-0.77
-0.83
-0.917
-0.85
Basic Average Shares
88,855,000
88,610,000
88,058,000
87,645,000
Diluted Average Shares
88,855,000
88,610,000
88,058,000
87,645,000
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Comprehensive loss
-$69,160K
Net loss
-$68,327K
(-3.33%↓ Y/Y)
Unrealized loss on
short-term investments
-$833K
Interest and other
income, net
$5,033K
(-27.43%↓ Y/Y)
Loss before income
taxes
-$68,322K
(-3.33%↓ Y/Y)
Income tax expense
$5K
Total other income,
net
$4,688K
(-28.36%↓ Y/Y)
License And
Collaboration Revenue
$11,752K
Product
$9,122K
Interest expense
$345K
(-11.76%↓ Y/Y)
Loss from operations
-$73,010K
(-0.47%↓ Y/Y)
Total revenue
$20,874K
(36.54%↑ Y/Y)
Total operating
expenses
$93,884K
(6.74%↑ Y/Y)
Research and development
$61,891K
(-1.42%↓ Y/Y)
Selling, general and
administrative
$31,750K
Cost of product sales
$243K
Buy us a coffee
Kura Oncology, Inc. (KURA)
Kura Oncology, Inc. (KURA)